Repligen (FRA:RGN) Total Tax Payable : €1.8 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Repligen Total Tax Payable?

Repligen's Total Tax Payable for the quarter that ended in Mar. 2024 was €1.8 Mil.

Repligen's quarterly Total Tax Payable increased from Sep. 2023 (€2.3 Mil) to Dec. 2023 (€6.2 Mil) but then declined from Dec. 2023 (€6.2 Mil) to Mar. 2024 (€1.8 Mil).

Repligen's annual Total Tax Payable declined from Dec. 2021 (€4.4 Mil) to Dec. 2022 (€2.3 Mil) but then increased from Dec. 2022 (€2.3 Mil) to Dec. 2023 (€6.2 Mil).

Repligen Total Tax Payable Historical Data

The historical data trend for Repligen's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen Total Tax Payable Chart

Repligen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

3.49

1.17

4.41

2.32

6.25

Repligen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Tax Payable	Get a 7-Day Free Trial															2.57	4.34	2.29	6.25	1.83

Repligen Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Repligen Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Repligen's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Repligen (FRA:RGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

RGEN:USA RGN:Germany

Address

41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453

Website

https://www.repligen.com

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Repligen (FRA:RGN) Headlines

No Headlines